share_log

Teladoc Health | 8-K: Teladoc Health Reports Fourth Quarter and Full Year 2023 Results

Teladoc Health | 8-K:Teladoc Health 報告 2023 年第四季度和全年業績

美股sec公告 ·  02/20 16:21
Moomoo AI 已提取核心訊息
Teladoc Health, Inc., a global leader in virtual care, reported its financial results for the fourth quarter and full year of 2023 on February 20, 2024. The company announced a 4% revenue increase for the fourth quarter, reaching $660.5 million, and an 8% increase for the full year, totaling $2.602 billion. Despite these gains, Teladoc Health experienced a net loss of $28.9 million, or $0.17 per share, in the fourth quarter, and a significant reduction in net loss from the previous year, with a full-year net loss of $220.4 million, or $1.34 per share. The company highlighted a 22% increase in fourth-quarter adjusted EBITDA to $114.4 million and a 33% increase for the full year to $328.1 million, marking its most profitable year to date. Operating cash flow for the year rose to...Show More
Teladoc Health, Inc., a global leader in virtual care, reported its financial results for the fourth quarter and full year of 2023 on February 20, 2024. The company announced a 4% revenue increase for the fourth quarter, reaching $660.5 million, and an 8% increase for the full year, totaling $2.602 billion. Despite these gains, Teladoc Health experienced a net loss of $28.9 million, or $0.17 per share, in the fourth quarter, and a significant reduction in net loss from the previous year, with a full-year net loss of $220.4 million, or $1.34 per share. The company highlighted a 22% increase in fourth-quarter adjusted EBITDA to $114.4 million and a 33% increase for the full year to $328.1 million, marking its most profitable year to date. Operating cash flow for the year rose to $350 million, with free cash flow increasing to $193.7 million. Teladoc Health also provided guidance for 2024, expecting revenue between $2.635 and $2.735 billion, and adjusted EBITDA between $350 and $390 million. The company's CEO, Jason Gorevic, emphasized progress in generating higher margins and strong bottom-line performance despite a challenging macro-economic environment. Teladoc Health's efficiency program is projected to yield pre-tax expense reductions of approximately $43 million in 2024, with annualized savings of about $85 million.
虛擬醫療領域的全球領導者Teladoc Health, Inc. 於2024年2月20日公佈了其2023年第四季度和全年財務業績。該公司宣佈第四季度收入增長4%,達到6.605億美元,全年收入增長8%,總額爲26.02億美元。儘管取得了這些收益,但Teladoc Health在第四季度淨虧損2890萬美元,合每股虧損0.17美元,淨虧損比上年大幅減少,全年淨虧損2.204億美元,合每股虧損1.34美元。該公司強調,第四季度調整後的息稅折舊攤銷前利潤增長22%,至1.144億美元,全年增長33%,達到3.281億美元,這是迄今爲止最賺錢的一年。該年度的運營現金流增至3.5億美元,自由現金流增加到...展開全部
虛擬醫療領域的全球領導者Teladoc Health, Inc. 於2024年2月20日公佈了其2023年第四季度和全年財務業績。該公司宣佈第四季度收入增長4%,達到6.605億美元,全年收入增長8%,總額爲26.02億美元。儘管取得了這些收益,但Teladoc Health在第四季度淨虧損2890萬美元,合每股虧損0.17美元,淨虧損比上年大幅減少,全年淨虧損2.204億美元,合每股虧損1.34美元。該公司強調,第四季度調整後的息稅折舊攤銷前利潤增長22%,至1.144億美元,全年增長33%,達到3.281億美元,這是迄今爲止最賺錢的一年。該年度的運營現金流增至3.5億美元,自由現金流增加到1.937億美元。Teladoc Health還提供了2024年的指導,預計收入在26.35億美元至27.35億美元之間,調整後的息稅折舊攤銷前利潤在3.5億美元至3.9億美元之間。該公司首席執行官傑森·戈雷維奇強調,儘管宏觀經濟環境充滿挑戰,但在創造更高的利潤率和強勁的利潤率方面取得了進展。Teladoc Health的效率計劃預計將在2024年減少約4,300萬美元的稅前支出,年化節省約8500萬美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息